Back
Armata Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
48
ARMP
Armata Pharmaceuticals
Last Price:
$2.07
Seasonality Move:
10.32%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARMP is experiencing selling pressure, which indicates risk of future bearish movement.
Armata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.99 | Buy |
| 20-day SMA: | 2.11 | Sell |
| 50-day SMA: | 2.25 | Sell |
| 200-day SMA: | 2.64 | Sell |
| 8-day EMA: | 2.02 | Buy |
| 20-day EMA: | 2.09 | Sell |
| 50-day EMA: | 2.21 | Sell |
| 200-day EMA: | 2.51 | Sell |
Armata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 42.87 | Sell |
| Chaikin Money Flow: | -6840 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.01 - 2.25) | Sell |
| Bollinger Bands (100): | (2.15 - 2.47) | Sell |
Armata Pharmaceuticals Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 2.02 while ARMP 8-day simple moving average is 1.99, which is a Buy signal.
-
The stock price of ARMP is 2.02 while Armata Pharmaceuticals 20-day SMA is 2.11, which makes it a Sell.
-
Armata Pharmaceuticals 50-day simple moving average is 2.25 while ARMP share price is 2.02, making it a Sell technically.
-
ARMP stock price is 2.02 and Armata Pharmaceuticals 200-day simple moving average is 2.64, creating a Sell signal.
ARMP Technical Analysis vs Fundamental Analysis
Sell
48
Armata Pharmaceuticals (ARMP)
is a Sell
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a SellThe current Armata Pharmaceuticals [ARMP] share price is $2.02. The Score for ARMP is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
73.1M
Price in USD:
2.02
Share Volume:
6.8K
Armata Pharmaceuticals 52-Week Range
52-Week High:
4.48
52-Week Low:
1.85
Sell
48
Armata Pharmaceuticals (ARMP)
is a Sell
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?The Armata Pharmaceuticals stock price is 2.02 USD today.
-
Will ARMP stock go up or go down?Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Armata Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is overvalued.
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 2.02 while ARMP 8-day exponential moving average is 2.02, which is a Buy signal.
-
The stock price of ARMP is 2.02 while Armata Pharmaceuticals 20-day EMA is 2.09, which makes it a Sell.
-
Armata Pharmaceuticals 50-day exponential moving average is 2.21 while ARMP share price is 2.02, making it a Sell technically.
-
ARMP stock price is 2.02 and Armata Pharmaceuticals 200-day simple moving average is 2.51, creating a Sell signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $0.75 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
-
ARMP Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Armata Pharmaceuticals is a Sell
-
Armata Pharmaceuticals Relative Strength Index (RSI) is 42.87, which suggest Armata Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Armata Pharmaceuticals is (2.01 - 2.25), which suggest Armata Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Armata Pharmaceuticals is (2.15 - 2.47), which suggest Armata Pharmaceuticals is a Sell
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.